March 2010 April 2010 May 2010 June 2010 July 2010
August 2010
September 2010 October 2010
November 2010
December 2010
January 2011
February 2011 March 2011 April 2011 May 2011 June 2011 July 2011 August 2011 September 2011 October 2011 November 2011 December 2011 January 2012 February 2012 March 2012 April 2012 May 2012 June 2012 July 2012 August 2012 September 2012 October 2012 November 2012 December 2012 January 2013 February 2013 March 2013 April 2013 May 2013 June 2013 July 2013 August 2013 September 2013 October 2013 November 2013 December 2013 January 2014 February 2014 March 2014 April 2014 May 2014 June 2014 July 2014 August 2014 September 2014 October 2014 November 2014 December 2014 January 2015 February 2015 March 2015 April 2015 May 2015 June 2015 July 2015 August 2015 September 2015 October 2015 November 2015 December 2015 January 2016 February 2016 March 2016 April 2016 May 2016 June 2016 July 2016 August 2016 September 2016 October 2016 November 2016 December 2016 January 2017 February 2017 March 2017 April 2017 May 2017 June 2017 July 2017 August 2017 September 2017 October 2017 November 2017 December 2017 January 2018 February 2018 March 2018 April 2018 May 2018 June 2018 July 2018 August 2018 September 2018 October 2018 November 2018 December 2018 January 2019 February 2019 March 2019 April 2019 May 2019 June 2019 July 2019 August 2019 September 2019 October 2019 November 2019 December 2019 January 2020 February 2020 March 2020 April 2020 May 2020 June 2020 July 2020 August 2020 September 2020 October 2020 November 2020 December 2020 January 2021 February 2021 March 2021 April 2021 May 2021 June 2021 July 2021 August 2021 September 2021 October 2021 November 2021 December 2021 January 2022 February 2022 March 2022 April 2022 May 2022 June 2022 July 2022 August 2022 September 2022 October 2022 November 2022 December 2022 January 2023 February 2023 March 2023 April 2023 May 2023 June 2023 July 2023 August 2023 September 2023 October 2023 November 2023 December 2023 January 2024 February 2024 March 2024
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
30
31
News Every Day |

Should you get a COVID-19 booster shot now or wait until fall? Two immunologists help weigh the options

Should you get a COVID-19 booster shot now or wait until fall? Two immunologists help weigh the options

(The Conversation) - While COVID-19 vaccines continue to be highly effective at preventing hospitalization and death, it has become clear that the protection offered by the current vaccines wanes over time. This necessitates the use of booster shots that are safe and effective in enhancing the immune response against the virus and extending protection.

But when to get a first or second booster, and which shot to choose, are open questions. Many people find themselves unsure whether to wait on new, updated formulations of the COVID-19 vaccines or to mix and match combinations of the original vaccine strains.

SARS-CoV-2, the virus that causes COVID-19, uses its knob-shaped spike protein to gain entry into cells and to cause infection. Each of the existing and upcoming vaccines relies on emulating the spike protein to trigger the immune response. However, each vaccine type presents the spike protein to the immune system in different ways.

As immunologists studying inflammatory and infectious diseases, including COVID-19, we are interested in understanding how the COVID-19 vaccine designs differ in the type of immunity they trigger and the protection that results.

New bivalent vaccines

Moderna and Pfizer-BioNTech, the two companies whose mRNA vaccines have been the primary options for COVID-19 vaccination across all age groups, both have new vaccine formulations on the way. An advisory committee of the Food and Drug Administration is set to meet on June 28, 2022, to evaluate the newest versions and to decide on which are likely to be recommended for use in this fall’s booster shots.

Moderna’s new bivalent vaccine mixes mRNA that encodes for the spike proteins of the original SARS-CoV-2 virus as well as the slightly different spike protein of the more infectious omicron variant.

In early June 2022, Moderna said that in clinical trials, its bivalent vaccine outcompetes the original vaccine strain, inducing a stronger immune response and longer protection against the original SARS-CoV-2 and its variants, including omicron.

Moderna later announced that its newest formulation also performs well against the newest omicron subvariants, BA.4 and BA.5, which are quickly becoming the dominant strains in the U.S. Because of the significantly stronger immune response that the new shot induces, Moderna predicts that such protection may last a year and plans to introduce its new vaccine in August.The new Moderna booster could be available by fall 2022.

And most recently, on June 25, Pfizer-BioNTech also announced results for its two new COVID-19 vaccine formulations: a bivalent formulation consisting of mRNA that encodes for the spike proteins of the original SARS-CoV-2 strain and the original BA.1 omicron subvariant, and a “monovalent” version that is only directed at the spike protein of BA.1.

The company’s preliminary studies demonstrated that both the monovalent and the bivalent vaccines triggered antibodies that neutralized the newer omicron BA.4 and BA.5 subvariants, although to a lesser degree than the BA.1 subvariant. However, Pfizer’s monovalent vaccine triggered better virus-neutralizing antibodies against the omicron BA.1 subvariant than did the bivalent vaccine.

However, whether the differences in the levels of such antibodies seen with the monovalent versus bivalent vaccines translate into different levels of protection against newer omicron variants remains to be established in clinical trials.

Progress on the Novavax vaccine

Another vaccine formulation that is working its way toward authorization is Novavax, a vaccine built using the spike protein of the original SARS-CoV-2 virus. The Novavax vaccine has the advantage of being similar to traditional vaccines, such as the DTaP vaccines against diphtheria, tetanus and pertussis, or the vaccines against other viral infections such as hepatitis and shingles. The Novavax vaccine has been clinically tested in South Africa, the United Kingdom and the U.S. and found to be safe and highly effective with 90% efficacy against mild, moderate and severe forms of COVID-19.

An advisory committee to the Food and Drug Administration endorsed the Novavax vaccine in early June 2022. Now, the FDA is reviewing changes that Novavax made during its manufacturing process before making its decision to authorize the shot.

In Australia, the Novavax vaccine was recently registered provisionally as a booster for individuals aged 18 years and over. The company is performing phase 3 clinical trials to determine if its vaccine can be used safely and effectively as a booster in people who have previously taken mRNA vaccines.

When these new vaccines become available in the coming months, people will have significantly more options for mixing and matching vaccines in order to enhance the duration and quality of their immune protection against COVID-19.Novavax does not need to be frozen, so storage and delivery of the vaccine is much easier.

Mixing and matching

Until then, clinical studies have shown that even mixing and matching the existing vaccine types is an effective strategy for boosting. For example, recent studies suggest that when adults who were fully vaccinated with any of the original three COVID-19 vaccines – Pfizer-BioNTech, Moderna or Johnson & Johnson – received a booster dose with a different vaccine brand from the one they received in their initial series, they had a similar or more robust immune response compared to boosting with the same brand of vaccine.

Vaccine mixing has been found to be safe and effective in various studies. The reason why mixing vaccines might produce a more robust immune response goes back to how each one presents the spike protein of the virus to the immune system.

???? Download the KSNT 27 News to stay updated on the go.

???? Sign up for KSNT 27 News email alerts to have breaking news sent to your inbox.

???? Find today’s Top Stories on KSNT.com for Topeka and Northeast Kansas.

When the SARS-CoV-2 virus mutates in regions of the spike protein, as has been the case with each of the variants and subvariants, and tries to evade the immune cells, antibodies that recognize different parts of the spike protein can stop it in its tracks and prevent the virus from infecting the body’s cells.

So whether you decide to get a booster shot now or wait until the fall, for many it’s heartening to know that more options are on the way.

Москва

В Подмосковье сотрудники Росгвардии задержали подозреваемых в кражах из сетевого супермаркета

Top 5 Websites to Watch FREE Movies - TV Shows (No Sign up!)

Top 10 Emmanuelle Seigner Movies

I was diagnosed with cancer aged 39… you are never too rich, too famous or too young, says Dr Philippa Kaye

Top 10 Love Affair Movies of the 2000s and 2010s

Ria.city






Read also

‘You’re going to finish them both?!’: Woman says a restaurant worker shamed her for ordering soup and salad

Why the New York Times Audience, and Its Editors, Find Peter Beinart so Appealing

Austin cutting down on number of scooters citywide

News, articles, comments, with a minute-by-minute update, now on Today24.pro

News Every Day

Top 10 Emmanuelle Seigner Movies

Today24.pro — latest news 24/7. You can add your news instantly now — here


News Every Day

Top 10 Emmanuelle Seigner Movies



Sports today


Новости тенниса
ATP

Хачанов победил Черундоло и пробился в 1/8 финала турнира ATP в Майами



Спорт в России и мире
Москва

GeekVape в сотрудничестве с Absolute Racing выиграла чемпионат в категории GT3



All sports news today





Sports in Russia today

Москва

«Радио Зенит» – информационный партнер форума «Мы вместе. Спорт»


Новости России

Game News

Teeny Tiny Trains — новая мобильная игра по типу Railbound


Russian.city


Москва

Шапки женские вязаные на Wildberries, 2024 — новый цвет от 392 руб. (модель 466)


Губернаторы России
Россия

Самые популярные туристические маршруты России: на автомобиле


Пассажир не успел войти в поезд и разбил стекло вагона на станции «Киевская»

Шапки женские вязаные на Wildberries, 2024 — новый цвет от 392 руб. (модель 466)

Сдавший участникам атаки на «Крокус» квартиру обжаловал Касимов свой арест

Чем опасны чесночная настойка и другие народные средства для защиты собаки от клещей, объяснил кинолог


Ольга Бузова стала человеком-невидимкой на ТВ-3 в новом сезоне легендарного шоу о звёздах

Семен Слепаков решил избавиться от последнего бизнеса в России

EMIN, Баста, Полина Гагарина, Валерия и другие артисты исполнили песни Муслима Магомаева

Тариф – Большой Концертный Тур. Организация серии больших концертов.


Теннисист Медведев вышел в полуфинал турнира в Майами, обыграв Харри

Хачанов победил Черундоло и пробился в 1/8 финала турнира ATP в Майами

Александрова впервые войдет в топ-15 мирового рейтинга

Россиянка покинула WTA-1000 из-за проблем со здоровьем



Архитектурные доминанты округов Москвы

Пассажир рейса Москва — Пермь попал в реанимацию

Шапки женские вязаные на Wildberries, 2024 — новый цвет от 392 руб. (модель 466)

«Радио Зенит» – информационный партнер форума «Мы вместе. Спорт»


Я – фартовая! Слушательница ENERGY отправилась в Мексику на выступление Джареда Лето

Консультации, Составление Договоров, Присутствие Продюсера при заключении договоров и переговорах. Лекции. Переговоры. Встречи и Обсуждения.

Путин отчитал Беглова за место Петербурга в туристическом рейтинге

Лавров заявил, что сфер сотрудничества России и Запада практически не осталось


В Подмосковье сотрудники Росгвардии задержали подозреваемых в кражах из сетевого супермаркета

Россия переходит ко второму акту Марлезонского балета

Боец MMA Минаков рассказал о своей мотивации для возвращения в спорт

В Минтрансе Подмосковья назвали оптимальные сроки замены авторезины на летнюю



Путин в России и мире






Персональные новости Russian.city
Сергей Шнуров

«Мое сердце у твоих ног»: Сергей Шнуров признался в симпатии одной из участниц «Новой Фабрики звезд»



News Every Day

Top 10 Emmanuelle Seigner Movies




Friends of Today24

Музыкальные новости

Персональные новости